6
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2561 | Macitentan | ACT-064992 | Apoptosis , Endothelin Receptor |
Macitentan (ACT-064992) is an endothelin receptor antagonist that is used in the therapy of pulmonary arterial hypertension (PAH). | |||
T11934 | Macitentan-d4 | Macitentan D4,ACT-064992 D4 | Endothelin Receptor |
Macitentan-d4 (ACT-064992 D4) is a deuterated substitute for Macitentan and can be used as a dual antagonist of the non-peptides ETA and ETB (endothelin receptor).Macitentan-d4 is less toxic than Macitentan, has a longer... | |||
T11935 | Macitentan (n-butyl analogue) | Others | |
Macitentan n-butyl analogue, a derivative of Macitentan, functions as an orally active dual antagonist targeting both endothelin ETA and ETB receptors. This compound shows promise for treating idiopathic pulmonary fibros... | |||
T7817 | Aprocitentan | ACT-132577 | Endothelin Receptor |
Aprocitentan (ACT-132577) is ETA and ETB antagonist . | |||
T35623 | ACT-373898 | ||
ACT-373898 is a metabolite of the endothelin (ET) receptor type A (ETA) and ETBdual antagonist macitentan .1 1.Dingemanse, J., Sidharta, P.N., Maddrey, W.C., et al.Efficacy, safety and clinical pharmacology of macitentan... | |||
T10351 | Aprocitentan D4 | ACT-132577 D4 | Others |
Aprocitentan D4 (ACT-132577 D4) is a deuterium-labeled Aprocitentan. Aprocitentan is a major and pharmacologically active metabolite of Macitentan. Aprocitentan is a dual ETA/ETB antagonist (IC50s: 3.4 nM and 987 nM; pA2... |